Related Experiment Video
Updated: May 13, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Copeptin adds prognostic information after ischemic stroke: results from the CoRisk study
Gian Marco De Marchis1, Mira Katan, Anja Weck
1Department of Neurology, Neuroradiology, and Clinical Chemistry, Inselspital, University of Bern, Switzerland.
Copeptin, a blood marker, accurately predicts outcomes and complications in acute ischemic stroke patients. It improves predictions beyond established clinical variables like stroke severity and age.
Area of Science:
- Neurology
- Biomarkers
- Stroke Medicine
Background:
- Accurate prediction of outcomes and complications in acute ischemic stroke is crucial for patient management.
- Established clinical variables may not fully capture the risk profile of stroke patients.
Purpose of the Study:
- To evaluate the incremental predictive value of copeptin compared to established clinical variables for stroke outcomes and complications.
- To validate copeptin as a prognostic biomarker in acute ischemic stroke.
Main Methods:
- Prospective, multicenter, cohort study of 783 acute ischemic stroke patients.
- Copeptin levels measured in emergency room within 24 hours of symptom onset.
- Primary endpoints: unfavorable functional outcome and mortality at 90 days; Secondary endpoints: in-hospital complications.
Main Results:
- Higher copeptin levels independently predicted unfavorable outcome, mortality, and complications.
- Adding copeptin significantly improved discriminatory accuracy for all endpoints.
- Copeptin combined with NIH Stroke Scale and age improved reclassification for functional outcome and mortality.
Conclusions:
- Copeptin is a validated blood marker that provides additional predictive information for functional outcome and mortality in ischemic stroke patients.
- Copeptin shows promise as a novel biomarker for predicting in-hospital complications.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Ischemic Stroke l: Introduction
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Ischemic Stroke ll: Pathophysiology
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...